Condition

Fluid Overload

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 19 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials19
Recruiting2
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

19 shown
Electric Cardiometry-Guided Standard Versus Restricted Fluid Therapy In Robotic ProstaectomyNCT07626151 · 2026-06-05
RECRUITING
The FILTRATE Trial: High-Rate Ultrafiltration for Intravascular CongestionNCT07705269 · 2026-06-04
RECRUITING
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart FailureNCT06995144 · 2025-05-01
WITHDRAWN
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0NCT06823115 · 2025-03-01
ENROLLING_BY_INVITATION
Naturally Controlled Decongestion Using Renal Independent System in ADHF Patients, a European RegistryNCT06401109 · 2025-02-01
UNKNOWN
Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in PreeclampsiaNCT06539026 · 2024-08-15
UNKNOWN
Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy VolunteersNCT06167707 · 2024-04-19
COMPLETED
Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)NCT05797649 · 2023-07-01
COMPLETED
THIRST Alert TrialNCT05869656 · 2023-05-03
COMPLETED
Determinants of Portal Vein Pulsatility IndexNCT06582368 · 2023-05-01
COMPLETED
Ultrafiltration Versus IV Diuretics in Worsening Heart FailureNCT05318105 · 2022-06-28
TERMINATED
Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1NCT05927285 · 2022-03-20
COMPLETED
Fluid unLoading On Weaning (FLOW)NCT04496583 · 2021-07-01
UNKNOWN
Hemodynamic Characteristics of Patients With SARS-CoV-2NCT04337983 · 2020-03-13
COMPLETED
A Feasibility Study on Ultrafiltration and Blood Volume MeasurementsNCT04241718 · 2019-12-19
TERMINATED
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent DosingNCT03746002 · 2019-01-01
TERMINATED
Ultrasound Markers of Organ Congestion in Severe Acute Kidney InjuryNCT04095143 · 2018-09-04
COMPLETED
Dialysate Sodium Lowering TrialNCT03144817 · 2017-04-26
COMPLETED
The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance AnalysisNCT00852514 · 2006-09-01
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED9
TERMINATED3
UNKNOWN3
RECRUITING2
ENROLLING_BY_INVITATION1
WITHDRAWN1

Phase mix

NA9
PHASE43
PHASE11
PHASE21
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.